Audited Results of Epigral Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	2,550.13	1,929.19	2,188.40	1,550.94	828.60
Manufacturing Expenses	130.08	105.75	122.89	41.13	4.42
Personnel Expenses	114.48	89.65	86.60	76.79	53.61
Selling Expenses	0	0	0	17.02	4.50
Administrative Expenses	185.55	137.39	122.37	105.18	92.25
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,839.41	1,447.98	1,499.40	1,041.45	567.27
Operating Profit	710.72	481.21	689	509.49	261.33
Other Recurring Income	15.21	6.51	7.98	4.11	2.19
Adjusted PBDIT	725.93	487.72	696.98	513.60	263.52
Financial Expenses	53.27	73.49	65.50	44.27	29.11
Depreciation	132.56	123.56	108.95	85.91	73.54
Other Write offs	0	0	0	0	0
Adjusted PBT	540.10	290.67	522.53	383.42	160.86
Tax Charges	183.40	94.88	169.17	130.64	60.02
Adjusted PAT	356.70	195.79	353.36	252.79	100.84
Non Recurring Items	-0.42	-0.48	0.23	-0.03	-0.18
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	356.70	195.79	353.36	252.79	100.84
Equity Dividend	31.56	10.39	10.39	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	1,783.94	1,459.22	1,274.30	931.10	678.34

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article